Cargando…

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma

The soluble carrier (SLC) family plays an important role in cell metabolism. The purpose of the current study was to screen SLCs as potential prognostic factors in clear cell renal cell carcinoma (ccRCC). A total of 509 patients with ccRCC from The Cancer Genome Atlas (TCGA) cohort were enrolled in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fangning, Wan, Chunguang, Ma, Hailiang, Zhang, Guohai, Shi, Yao, Zhu, Bo, Dai, Yijun, Shen, Yiping, Zhu, Dingwei, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559962/ https://www.ncbi.nlm.nih.gov/pubmed/28819401 http://dx.doi.org/10.7150/jca.18257

Ejemplares similares

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
por: Wu, Junlong, et al.
Publicado: (2017)

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
por: Wang, Beihe, et al.
Publicado: (2017)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
por: Zhang, Guiming, et al.
Publicado: (2015)

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
por: Wang, Yuchen, et al.
Publicado: (2021)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
por: Wang, Beihe, et al.
Publicado: (2019)

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data
por: Tian, Xi, et al.
Publicado: (2020)

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway
por: Wang, HongKai, et al.
Publicado: (2017)

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
por: Luo, Wenjie, et al.
Publicado: (2021)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
por: Shao, Ning, et al.
Publicado: (2019)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
por: Wan, Fangning, et al.
Publicado: (2014)

A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer
por: Shao, Ning, et al.
Publicado: (2020)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

Causes of Death and Conditional Survival of Renal Cell Carcinoma
por: Shao, Ning, et al.
Publicado: (2019)

Extramammary Paget’s diseases in men from the Shanghai area: its association with PSA level increase*
por: SHI, GUOHAI, et al.
Publicado: (2010)

Complicated variation of simple renal cyst usually means malignancy: results from a cohort study
por: Qin, XiaoJian, et al.
Publicado: (2014)

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma
por: Zeng, Bohan, et al.
Publicado: (2020)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series
por: Gu, Weijie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1p3rqk0s6q3978qftbrodiepcj